Total Payments
$4,609
2024 Payments
$519.91
Companies
18
Transactions
281
Medicare Patients
431
Medicare Billing
$80,930
Payment Breakdown by Category
Food & Beverage$4,463 (96.8%)
Education$145.87 (3.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,463 | 278 | 96.8% |
| Education | $145.87 | 3 | 3.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Sunovion Pharmaceuticals Inc. | $778.41 | 41 | $0 (2022) |
| Teva Pharmaceuticals USA, Inc. | $558.57 | 39 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $494.25 | 27 | $0 (2022) |
| ITI, Inc. | $478.37 | 21 | $0 (2023) |
| ABBVIE INC. | $466.97 | 33 | $0 (2024) |
| Allergan, Inc. | $433.58 | 49 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $427.89 | 24 | $0 (2024) |
| Alkermes, Inc. | $352.58 | 15 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $230.12 | 9 | $0 (2024) |
| Lundbeck LLC | $83.12 | 6 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $519.91 | 24 | Neurocrine Biosciences, Inc. ($107.65) |
| 2023 | $622.66 | 27 | Teva Pharmaceuticals USA, Inc. ($188.21) |
| 2022 | $610.85 | 34 | ABBVIE INC. ($148.07) |
| 2021 | $670.10 | 37 | ITI, Inc. ($264.95) |
| 2020 | $385.06 | 26 | Allergan, Inc. ($150.03) |
| 2019 | $688.37 | 52 | Sunovion Pharmaceuticals Inc. ($215.82) |
| 2018 | $707.96 | 59 | Sunovion Pharmaceuticals Inc. ($178.03) |
| 2017 | $403.62 | 22 | Sunovion Pharmaceuticals Inc. ($115.76) |
All Payment Transactions
281 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: OUD | ||||||
| 12/09/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $26.65 | General |
| Category: Neuropsychiatry | ||||||
| 11/20/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $17.05 | General |
| 11/04/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $29.26 | General |
| Category: Psychology/Psychiatric | ||||||
| 11/01/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $17.63 | General |
| Category: Central Nervous System | ||||||
| 10/16/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $14.15 | General |
| Category: PSYCHIATRY | ||||||
| 10/07/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $32.71 | General |
| Category: CNS | ||||||
| 09/27/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: Central Nervous System | ||||||
| 09/23/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $22.86 | General |
| Category: Neuroscience | ||||||
| 08/19/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $20.69 | General |
| Category: Neuroscience | ||||||
| 07/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: NEUROSCIENCE | ||||||
| 07/01/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $26.74 | General |
| Category: Neuropsychiatry | ||||||
| 06/13/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $25.54 | General |
| Category: PSYCHIATRY | ||||||
| 06/06/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $17.55 | General |
| Category: PSYCHIATRY | ||||||
| 06/03/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $25.20 | General |
| Category: CNS | ||||||
| 05/30/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $22.02 | General |
| Category: Neurology | ||||||
| 05/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.38 | General |
| Category: NEUROSCIENCE | ||||||
| 04/08/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $28.99 | General |
| Category: Neurology | ||||||
| 04/01/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $25.98 | General |
| Category: Neuropsychiatry | ||||||
| 03/07/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $28.28 | General |
| Category: Neuropsychiatry | ||||||
| 02/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: NEUROSCIENCE | ||||||
| 02/23/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: PSYCHIATRY | ||||||
| 01/22/2024 | Indivior Inc. | PERSERIS (Drug) | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: BH | ||||||
| 01/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.80 | General |
| Category: NEUROSCIENCE | ||||||
| 12/23/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $11.00 | General |
| Category: CNS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 97 | 265 | $46,995 | $18,379 |
| 2022 | 2 | 102 | 255 | $48,645 | $20,252 |
| 2021 | 2 | 108 | 290 | $58,629 | $24,669 |
| 2020 | 2 | 124 | 276 | $45,818 | $17,630 |
Total Patients
431
Total Services
1,086
Medicare Billing
$80,930
Procedure Codes
8
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 39 | 115 | $24,495 | $9,785 | 39.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 58 | 150 | $22,500 | $8,594 | 38.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 54 | 165 | $35,145 | $14,960 | 42.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 48 | 90 | $13,500 | $5,292 | 39.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 71 | 240 | $51,120 | $21,690 | 42.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 37 | 50 | $7,509 | $2,979 | 39.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 80 | 211 | $37,803 | $14,624 | 38.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 44 | 65 | $8,015 | $3,006 | 37.5% |
About Dr. Brian Monette, MD
Dr. Brian Monette, MD is a Addiction Medicine healthcare provider based in Gonzales, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1699781591.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brian Monette, MD has received a total of $4,609 in payments from pharmaceutical and medical device companies, with $519.91 received in 2024. These payments were reported across 281 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($4,463).
As a Medicare-enrolled provider, Monette has provided services to 431 Medicare beneficiaries, totaling 1,086 services with total Medicare billing of $80,930. Data is available for 4 years (2020–2023), covering 8 distinct procedure/service records.
Ad
Practice Information
- Specialty Addiction Medicine
- Other Specialties Psychiatry, Child & Adolescent Psychiatry
- Location Gonzales, LA
- Active Since 07/31/2006
- Last Updated 01/25/2012
- Taxonomy Code 2084A0401X
- Entity Type Individual
- NPI Number 1699781591
Products in Payments
- VRAYLAR (Drug) $900.55
- LATUDA (Drug) $778.41
- CAPLYTA (Drug) $550.39
- REXULTI (Drug) $539.75
- AUSTEDO (Drug) $299.30
- INVEGA SUSTENNA (Drug) $284.05
- ARISTADA (Drug) $262.92
- INGREZZA (Drug) $230.12
- UZEDY (Drug) $179.24
- INVEGA TRINZA (Drug) $92.88
- Fanapt (Drug) $72.82
- Austedo XR (Drug) $64.23
- Auvelity (Drug) $60.52
- SPRAVATO (Drug) $50.96
- Aristada 441 mg (Drug) $46.65
- ABILIFY MAINTENA (Drug) $37.62
- SECUADO (Drug) $26.17
- LYBALVI (Drug) $23.37
- Dayvigo (Drug) $22.44
- Vivitrol 380 mg (Drug) $19.64
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.